Skip to main content

Allergan

(

AGN

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.8%. By the end of trading, Allergan fell $1.07 (-1.2%) to $90.04 on average volume. Throughout the day, 1.9 million shares of Allergan exchanged hands as compared to its average daily volume of 1.5 million shares. The stock ranged in price between $88.88-$90.74 after having opened the day at $90.74 as compared to the previous trading day's close of $91.11. Other company's within the Health Care sector that declined today were:

Anthera Pharmaceuticals

(

ANTH

), down 70.7%,

Synta Pharmaceuticals

(

SNTA

), down 33.5%,

D Medical Industries

(

DMED

), down 23.7%, and

TheStreet Recommends

NeurogesX

(

NGSX

), down 22.2%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $27.32 billion and is part of the

drugs

industry. The company has a P/E ratio of 27.8, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 2.6% year to date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Allergan a buy, one analyst rates it a sell, and eight rate it a hold.

TheStreet Ratings rates Allergan as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front,

Foundation SunLink Healthcare Affiliates In

(

SSY

), up 24.2%,

Synergetics USA

(

SURG

), up 22.7%,

Orexigen Therapeutics

(

OREX

), up 19.9%, and

Chelsea Therapeutics International

(

CHTP

), up 12.1%, were all gainers within the health care sector with

Laboratory Corporation of America Holdings

(

LH

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null